← CRISPR Therapeutics

What podcasts say about CRISPR Therapeutics

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about CRISPR Therapeutics

1 statement · 1 mixed

  1. CRISPR Therapeutics is interesting long term but unattractive for 2026.

    “Long term, very interesting. Short term, 2026, not interested.”

    Listen at 31:35

    Open the episode · RBA raises rates again, Pimp my Portfolio with Henry Jennings & we review the community portfolio

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.